Latest Insider Transactions at Biocryst Pharmaceuticals Inc (BCRX)
This section provides a real-time view of insider transactions for Biocryst Pharmaceuticals Inc (BCRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOCRYST PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOCRYST PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2020
|
Alane P Barnes Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,741
+10.14%
|
$54,964
$4.15 P/Share
|
|
Nov 30
2020
|
Robert Alexander Ingram Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,669
+4.77%
|
$18,345
$5.11 P/Share
|
|
Nov 30
2020
|
Nancy J Hutson Director |
BUY
Grant, award, or other acquisition
|
Direct |
978
+1.5%
|
$4,890
$5.11 P/Share
|
|
Nov 30
2020
|
Steve Aselage Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,956
+6.01%
|
$9,780
$5.11 P/Share
|
|
Nov 30
2020
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
978
+6.81%
|
$4,890
$5.11 P/Share
|